Newsfeeds Archive - Page 4 of 4

2 minute read

Short Interest Sector Focus: Healthcare Sector

August 30, 12:29 PM

As of the close of business on Monday, 8/29, we captured the Top 10 Highest Short Interest % stocks within the Healthcare Sector. The average short interest for stocks within the Healthcare sector stands at 3.49%. Therefore, the below stocks are showing a more pessimistic outlook than their peers within the respective sector.

APYX

8 minute read

Why Embark Technology Jumped Around 85%; Here Are 108 Biggest Movers From Friday

By Lisa Levin

Yesterday, 3:43 AM

Gainers Embark Technology, Inc. (NASDAQ: EMBK) jumped 84.8% to close at $1.07 on Friday after the company reported better-than-expected Q2 EPS results.

ACRX

6 minute read

Why Twin Vee Powercats Is Trading Higher By Around 90%, Here Are 84 Stocks Moving In Friday’s Mid-Day Session

By Lisa Levin

August 12, 12:54 PM

Gainers Twin Vee Powercats Co. (NASDAQ: VEEE) shares jumped 90% to $7.60 after the company said Q2 sales results were up year over year.

ACRX

17 minute read

Earnings Scheduled For August 11, 2022

By Benzinga Insights

August 11, 5:09 AM

Companies Reporting Before The Bell • Magic Software (NASDAQ:MGIC) is projected to report quarterly earnings at $0.27 per share on revenue of $131.70 million.

AACG

3 minute read

Recap of Monday’s Biotech Catalysts – End of the Day Summary

By Ragothaman Srinivasan

July 18, 6:07 PM

Abbvie (NYSE: ABBV) has submitted a marketing authorization application (MAA) to the European Medicines Agency (EMA) for atogepant for the prophylaxis of migraine in adult patients who have at least four migraine days per month.

ABBV

1 minute read

Apyx Medical’s Renuvion Scores FDA Approval To Eliminate Sagging Neck

By Vandana Singh

July 18, 10:40 AM

The FDA has granted 510(k) clearance for Apyx Medical Corporation’s (NASDAQ:APYX) Renuvion for subcutaneous dermatological and aesthetic procedures to improve the appearance…

APYX

4 minute read

FDA
News

Apyx Medical Corporation Announces Results Of The U.S. Ide Clinical Study Evaluating The Use Of Renuvion To Improve The Appearance Of Lax Skin In The Neck And Submental Region; Says Primary Effectiveness Endpoint Of Study Was Met

By Benzinga Newsdesk

July 8, 3:54 PM

Apyx Medical Corporation (NASDAQ:APYX) (the "Company"), the manufacturer of a proprietary helium plasma and radiofrequency technology marketed and sold as Renuvion®, today announced that the results of

APYX